NAMAX | VMVAX | NAMAX / VMVAX | |
Total Expense Ratio | 0.90 | 0.07 | 1,286% |
Annual Report Gross Expense Ratio | 0.90 | 0.07 | 1,286% |
Fund Existence | 24 years | 14 years | - |
Gain YTD | 2.821 | 3.573 | 79% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.46B | 29.9B | 8% |
Annual Yield % from dividends | 0.92 | 2.26 | 41% |
Returns for 1 year | 4.29 | 12.14 | 35% |
Returns for 3 years | 27.09 | 28.52 | 95% |
Returns for 5 years | 68.17 | 77.08 | 88% |
Returns for 10 years | -8.62 | 88.11 | -10% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CLPAX | 14.01 | 0.18 | +1.30% |
Catalyst Nasdaq-100 Hedged Equity A | |||
BDFIX | 35.19 | 0.29 | +0.83% |
Baron Discovery Institutional | |||
MIRTX | 34.93 | 0.28 | +0.81% |
MFS Massachusetts Investors Tr R2 | |||
BPSIX | 27.08 | 0.21 | +0.78% |
Boston Partners Small Cap Value II I | |||
TPVIX | 19.73 | 0.08 | +0.41% |
Timothy Plan Small Cap Value I |